Olanzapine-based vs neurokinin-1 receptor antagonist antiemetic regimens in highly emetogenic chemotherapy: Systematic review and meta-analysis of efficacy and safety

doi:10.12998/wjcc.v14.i12.119112

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 12

This Article

(47)

(102)

(0)

(13)

(763)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Clin Cases. Apr 26, 2026; 14(12): 119112
Published online Apr 26, 2026. doi: 10.12998/wjcc.v14.i12.119112

Full Size Figure Download Figure

Figure 3 Risk of bias assessment for cohort. A: Individual studies using the risk of bias in nonrandomized studies of interventions version I tool; B: Overall studies using the risk of bias in nonrandomized studies of interventions version I tool.

Citation: Mv A, Anand N, Babu B, Awosika A, Udayan U, Mendoza J, Lopez A, Rangachari B, Maity S, Gadad BS. Olanzapine-based vs neurokinin-1 receptor antagonist antiemetic regimens in highly emetogenic chemotherapy: Systematic review and meta-analysis of efficacy and safety. World J Clin Cases 2026; 14(12): 119112
URL: https://www.wjgnet.com/2307-8960/full/v14/i12/119112.htm
DOI: https://dx.doi.org/10.12998/wjcc.v14.i12.119112

Mv A, Anand N, Babu B, Awosika A, Udayan U, Mendoza J, Lopez A, Rangachari B, Maity S, Gadad BS. Olanzapine-based vs neurokinin-1 receptor antagonist antiemetic regimens in highly emetogenic chemotherapy: Systematic review and meta-analysis of efficacy and safety. World J Clin Cases 2026; 14(12): 119112 [DOI: 10.12998/wjcc.v14.i12.119112]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.